申请人:Plexxikon Inc.
公开号:US20210198239A1
公开(公告)日:2021-07-01
Disclosed are compounds of Formula I:
or a pharmaceutically acceptable salt, a solvate, a tautomer, a stereoisomer or a deuterated analog thereof, wherein R
1
, R
2
, R
3
, A, L, and G are as described in any of the embodiments described in this disclosure; compositions thereof; and uses thereof.